99
part 1: coronary artery bypass grafting surgery. Ann Thorac Surg 2009;88(1 Suppl):S2 – 22.
12.
Mohr FW, Morice MC, Kappetein AP, Feldman TE, Stahle E, Colombo A, Mack MJ, Holmes DR
Jr., Morel MA, Van Dyck N, Houle VM, Dawkins KD, Serruys PW. Coronary artery bypass graft
surgery vs. percutaneous coronary intervention in patients with three-vessel disease and left main
coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial. Lancet
2013;381(9867):629 – 638.
13.
Peterson ED, Dai D, DeLong ER, Brennan JM, Singh M, Rao SV, Shaw RE, Roe MT, Ho KK, Klein
LW, Krone RJ, Weintraub WS, Brindis RG, Rumsfeld JS, Spertus JA, Participants NR. Contemporary
mortality risk prediction for percutaneous coronary intervention: results from 588,398 procedures in
the National Cardiovascular Data Registry. J Am Coll Cardiol 2010;55(18):1923 – 1932.
14.
Ranucci M, Castelvecchio S, Menicanti L, Frigiola A, Pelissero G. Risk of assessing mortality risk in
elective cardiac operations: age, creatinine, ejection fraction, and the law of parsimony. Circulation
2009;119(24):3053 – 3061.
15.
Weintraub WS, Grau-Sepulveda MV, Weiss JM, O’Brien SM, Peterson ED, Kolm P, Zhang Z, Klein
LW, Shaw RE, McKay C, Ritzenthaler LL, Popma JJ, Messenger JC,
Shahian DM, Grover FL,
Mayer JE, Shewan CM, Garratt KN, Moussa ID, Dangas GD, Edwards FH. Comparative
effectiveness of revascularization strategies. N Engl J Med 2012;366(16):1467 – 1476.
16.
Chandrasekharan DP, Taggart DP. Informed consent for interventions in stable coronary artery
disease:
problems, etiologies, and solutions. Eur J Cardiothorac Surg 2011;39(6):912 – 917.
17.
Filardo G, Maggioni AP, Mura G, Valagussa F, Valagussa L, Schweiger C, Ballard DJ, Liberati A.
The consequences of under-use of coronary revascularization; results of a cohort study in Northern
Italy. Eur Heart J 2001;22(8):654 – 662.
18.
Yates MT, Soppa GK, Valencia O, Jones S, Firoozi S, Jahangiri M. Impact of European Society of
Cardiology and European Association for Cardiothoracic Surgery Guidelines on Myocardial
Revascularization on the activity of percutaneous coron- ary intervention
and coronary artery bypass
graft surgery for stable coronary artery disease. J Thorac Cardiovasc Surg 2014;147(2):606 – 610.
19.
Epstein AJ, Polsky D, Yang F, Yang L, Groeneveld PW. Coronary revascularization trends in the
United States, 2001 – 2008. JAMA 2011;305(17):1769 – 1776.
20.
Denvir MA, Pell JP, Lee AJ, Rysdale J, Prescott RJ, Eteiba H, Walker A, Mankad P, Starkey IR.
Variations in clinical decision-making between cardiologists and cardiac surgeons; a case for
management by multidisciplinary teams? J Cardiothorac Surg 2006;1:2.
21.
Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing and impact of
revascularization on prognosis in patients with coronary artery disease and left ventricular
dysfunction: a meta-analysis. J Am Coll Cardiol 2002;39(7): 1151 – 1158.
22.
Murthy VL, Naya M, Foster CR, Gaber M, Hainer J, Klein J, Dorbala S, Blankstein R, Di Carli MF.
Association between coronary vascular dysfunction and cardiac mortality in patients with and without
diabetes mellitus. Circulation 2012;126(15): 1858 – 1868.
23.
Kolh P, Wijns W, Danchin N,
Di Mario C, Falk V, Folliguet T, Garg S, Huber K, James S, Knuuti J,
Lopez-Sendon J, Marco J, Menicanti L, Ostojic M, Piepoli MF, Pirlet C, Pomar JL, Reifart N,
Ribichini FL, Schalij MJ, Sergeant P, Serruys PW, Silber S, Sousa Uva M, Taggart D. Guidelines on
myocardial revascularization. Eur J Cardiothorac Surg 2010;38 Suppl:S1 – S52.
24.
Wijns W, Kolh P, Danchin N, Di Mario C, Falk V, Folliguet T, Garg S, Huber K, James S, Knuuti J,
Lopez-Sendon J, Marco J, Menicanti L, Ostojic M, Piepoli MF, Pirlet C, Pomar JL, Reifart N,
Ribichini FL, Schalij MJ, Sergeant P, Serruys PW, Silber S, Sousa Uva M, Taggart D, Vahanian A,
Auricchio A, Bax J, Ceconi C, Dean V, Filippatos G, Funck-Brentano C, Hobbs R, Kearney P,
McDonagh T, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Vardas PE, Widimsky P,
Alfieri O, Dunning J, Elia S, Kappetein P, Lockowandt U, Sarris G, Vouhe P, von Segesser L,
Agewall S, Aladashvili A, Alexopoulos D, Antunes MJ, Atalar E, Brutel de la Riviere A, Doganov
100
A, Eha J, Fajadet J, Ferreira R, Garot J, Halcox J, Hasin Y, Janssens S, Kervinen K, Laufer G, Legrand
V, Nashef SA, Neumann FJ, Niemela K, Nihoyannopoulos P, Noc M, Piek JJ, Pirk J, Rozenman Y,
Sabate M, Starc R, Thielmann M, Wheatley DJ, Windecker S, Zembala M. Guidelines on myocardial
revascularization: The Task Force on Myocardial Revascularization of the European Society of
Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS).
Eur Heart J
2010;31(20):2501 – 2555.
25.
Deb S, Wijeysundera HC, Ko DT, Tsubota H, Hill S, Fremes SE. Coronary artery bypass graft surgery
vs.percutaneous interventions in coronary revascularization: a systematic review. JAMA
2013;310(19):2086 – 2095.
26.
Boden WE, O’Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, Knudtson M, Dada M,
Casperson P, Harris CL, Chaitman BR, Shaw L, Gosselin G, Nawaz S, Title LM, Gau G, Blaustein
AS, Booth DC, Bates ER, Spertus JA, Berman DS, Mancini GB, Weintraub WS, Group CTR. Optimal
medical therapy with or without PCI for stable coronary disease. N Engl J Med 2007;356(15):1503 –
1516.
27.
Hueb W, Lopes N, Gersh BJ, Soares PR, Ribeiro EE, Pereira AC, Favarato D, Rocha AS, Hueb AC,
Ramires JA. Ten-year follow-up survival of the Medicine, Angioplasty, or Surgery Study (MASS II):
a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery
disease. Circulation 2010; 122(10):949 – 957.
28.
Wijeysundera HC, Nallamothu BK, Krumholz HM, Tu JV, Ko DT. Meta-analysis: effects of
percutaneous coronary intervention vs. medical therapy on angina relief. Ann Intern Med
2010;152(6):370 – 379.
29.
Pursnani S, Korley F, Gopaul R, Kanade P, Chandra N, Shaw RE, Bangalore S. Percutaneous
coronary intervention vs. optimal medical therapy in stable coronary artery disease: a systematic
review and meta-analysis of randomized clinical trials. Circ Cardiovasc Interv 2012;5(4):476 – 490.
30.
Stergiopoulos K, Boden WE, Hartigan P, Mobius-Winkler S, Hambrecht R, Hueb W, Hardison RM,
Abbott JD, Brown DL. Percutaneous Coronary Interven- tion Outcomes in Patients With Stable
Obstructive Coronary Artery Disease and Myocardial Ischemia: A Collaborative Meta-analysis of
Contemporary Randomized Clinical Trials. JAMA Intern Med 2014;174(2):232 – 240.
31.
Califf RM, Armstrong PW, Carver JR, D’Agostino RB, Strauss WE. 27th Bethesda Conference:
matching the intensity of risk factor management with the hazard for coronary disease events. Task
Force 5.Stratification of patients into high, medium and low risk subgroups for purposes of risk factor
management. J Am Coll Cardiol 1996;27(5):1007 – 1019.
32.
Jeremias A, Kaul S, Rosengart TK, Gruberg L, Brown DL. The impact of revascular-ization on
mortality in patients with nonacute coronary artery disease. Am J Med 2009;122(2):152 – 161.
33.
Long-term results of prospective randomised study of coronary artery bypass surgery in stable angina
pectoris. European Coronary Surgery Study Group. Lancet 1982;2(8309):1173 – 1180.
34.
Eleven-year survival in the Veterans Administration randomized trial of coronary bypass surgery for
stable angina. The Veterans Administration Coronary Artery Bypass Surgery Cooperative Study
Group. N Engl J Med 1984;311(21):1333 – 1339.
35.
Myocardial infarction and mortality in the coronary artery surgery study (CASS) randomized trial. N
Engl J Med 1984;310(12):750 – 758.
36.
Hochman JS, Lamas GA, Buller CE, Dzavik V, Reynolds HR, Abramsky SJ, Forman S, Ruzyllo W,
Maggioni AP, White H, Sadowski Z, Carvalho AC, Rankin JM, Renkin JP, Steg PG, Mascette AM,
Sopko G, Pfisterer ME, Leor J, Fridrich V, Mark DB, Knatterud GL. Coronary intervention for
persistent occlusion after myocardial infarction. N Engl J Med 2006;355(23):2395 – 2407.
37.
Baber U, Mehran R, Sharma SK, Brar S, Yu J, Suh JW, Kim HS, Park SJ, Kastrati A, de Waha A,
Krishnan P,
Moreno P, Sweeny J, Kim MC, Suleman J, Pyo R, Wiley J, Kovacic J, Kini AS, Dangas
GD. Impact of the everolimus-eluting stent on stent thrombosis: a meta-analysis of 13 randomized